只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-17 2026-07-20 | OWLS OBOOK HOLDINGS INC. | WANG CHUN KAI Director,Officer · Chief Executive Officer | 买入（P） | 1,257 | US$5.61 | US$7,046.74 | 3,112,450 | SEC |
| 2026-07-14 2026-07-16 | OWLS OBOOK HOLDINGS INC. | WANG CHUN KAI Director,Officer · Chief Executive Officer | 买入（P） | 1,954 | US$5.67 | US$11,073.32 | 3,111,193 | SEC |
| 2026-07-14 2026-07-15 | BOT RoboStrategy, Inc. | Kang Andrew Kai Director,Officer,TenPercentOwner · President | 买入（P） | 272,405 | US$36.71 | US$1000万 | 2,027,687 | SEC |
| 2026-07-07 2026-07-07 | NGNE Neurogene Inc. | Cvijic Christine Mikail Director,Officer · President and CFO | 卖出（S） | 4,200 | US$36.13 | US$151,762.80 | 84,040 | SEC |
| 2026-07-06 2026-07-07 | NGNE Neurogene Inc. | Cvijic Christine Mikail Director,Officer · President and CFO | 卖出（S） | 600 | US$36.02 | US$21,612.60 | 88,240 | SEC |
| 2026-07-02 2026-07-02 | NGNE Neurogene Inc. | Cvijic Christine Mikail Director,Officer · President and CFO | 卖出（S） | 2,531 | US$34.58 | US$87,519.45 | 90,370 | SEC |
| 2026-07-02 2026-07-02 | NGNE Neurogene Inc. | Cvijic Christine Mikail Director,Officer · President and CFO | 卖出（S） | 1,530 | US$35.23 | US$53,897.31 | 88,840 | SEC |
| 2026-07-01 2026-07-02 | NGNE Neurogene Inc. | Cvijic Christine Mikail Director,Officer · President and CFO | 卖出（S） | 739 | US$34.06 | US$25,169.60 | 92,901 | SEC |
| 2026-06-10 2026-06-12 | OWLS OBOOK HOLDINGS INC. | WANG CHUN KAI Director,Officer · Chief Executive Officer | 买入（P） | 2,344 | US$5.72 | US$13,407.68 | 3,109,239 | SEC |
| 2026-05-27 2026-05-27 | KAI KADANT INC | KRAUSE STACY D. Officer · SVP, GC and Secretary | 卖出（S） | 1,227 | US$334.17 | US$410,026.59 | 1,363 | SEC |
| 2026-05-26 2026-05-28 | OCUL OCULAR THERAPEUTIX, INC | Kaiser Peter Officer · Chief Development Officer | 卖出（S） | 2,967 | US$8.20 | US$24,329.40 | 266,141 | SEC |
| 2026-05-22 2026-05-26 | OWLS OBOOK HOLDINGS INC. | WANG CHUN KAI Director,Officer · Chief Executive Officer | 买入（P） | 100 | US$5.64 | US$564.00 | 3,106,895 | SEC |
| 2026-05-18 2026-05-18 | KAI KADANT INC | Blanchard Thomas Andrew Officer · Vice President | 卖出（S） | 1,400 | US$322.04 | US$450,856.00 | 557 | SEC |
| 2026-05-13 2026-05-14 | COF CAPITAL ONE FINANCIAL CORP | Haggerty Kaitlin Officer · Chief Human Resources Officer | 卖出（S） | 119 | US$182.59 | US$21,728.21 | 49,181 | SEC |
| 2026-05-12 2026-05-14 | COF CAPITAL ONE FINANCIAL CORP | Haggerty Kaitlin Officer · Chief Human Resources Officer | 卖出（S） | 1,307 | US$183.93 | US$240,396.51 | 49,300 | SEC |
| 2026-05-06 2026-05-08 | NGNE Neurogene Inc. | Cvijic Christine Mikail Director,Officer · President and CFO | 卖出（S） | 4,800 | US$32.44 | US$155,712.00 | 93,640 | SEC |
| 2026-05-06 2026-05-08 | NGNE Neurogene Inc. | Cvijic Christine Mikail Director,Officer · President and CFO | 卖出（S） | 4,800 | US$30.07 | US$144,336.00 | 98,440 | SEC |
| 2026-05-04 2026-05-05 | CAT CATERPILLAR INC | Kaiser Jason Officer · Group President | 卖出（S） | 5,642 | US$883.03 | US$498.21万 | 9,594 | SEC |
| 2026-04-29 2026-05-01 | KALU KAISER ALUMINUM CORP | Harvey Keith Director,Officer · President & CEO | 卖出（S） | 3,031 | US$173.13 | US$524,757.03 | 94,308 | SEC |
| 2026-04-29 2026-05-01 | KALU KAISER ALUMINUM CORP | Grimley Richard P. Director | 卖出（S） | 1,524 | US$171.52 | US$261,396.48 | 4,578 | SEC |
| 2026-04-28 2026-04-29 | KALU KAISER ALUMINUM CORP | West Neal E Officer · EVP & CFO | 卖出（S） | 5,000 | US$173.29 | US$866,450.00 | 19,091 | SEC |
| 2026-04-27 2026-04-29 | KALU KAISER ALUMINUM CORP | Harvey Keith Director,Officer · President & CEO | 卖出（S） | 47,001 | US$175.09 | US$822.94万 | 97,339 | SEC |
| 2026-04-27 2026-04-29 | KALU KAISER ALUMINUM CORP | Gheorghe Iulian Officer · SVP - Adv Eng & Innovation | 卖出（S） | 175 | US$174.22 | US$30,488.50 | 4,448 | SEC |
| 2026-04-27 2026-04-29 | KALU KAISER ALUMINUM CORP | DONNAN JOHN MALCOLM Officer · EVP, CAO and GC | 卖出（S） | 2,743 | US$178.20 | US$488,802.60 | 29,700 | SEC |
| 2026-04-27 2026-04-29 | KALU KAISER ALUMINUM CORP | Wilcox Brett Director | 卖出（S） | 15,000 | US$174.44 | US$261.66万 | 9,887 | SEC |
| 2026-04-20 2026-04-22 | KLRA Kailera Therapeutics, Inc. | RTW INVESTMENTS, LP TenPercentOwner | 买入（P） | 500,000 | US$16.00 | US$800万 | 10,776,820 | SEC |
| 2026-04-20 2026-04-22 | KLRA Kailera Therapeutics, Inc. | WONG RODERICK TenPercentOwner | 买入（P） | 500,000 | US$16.00 | US$800万 | 10,776,820 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Kaplan Andrew T. Director,TenPercentOwner | 买入（P） | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BCLS Fund IV Investments GP, LLC TenPercentOwner | 买入（P） | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BCLS Fund IV Investments, L.P. TenPercentOwner | 买入（P） | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital Life Sciences Fund IV, L.P. TenPercentOwner | 买入（P） | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital Life Sciences IV General Partner, LLC TenPercentOwner | 买入（P） | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital Life Sciences Investors, LLC TenPercentOwner | 买入（P） | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Koppel Adam Director,TenPercentOwner | 买入（P） | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BCPE Perseus Investor, LP TenPercentOwner | 买入（P） | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital Fund XIV, L.P. TenPercentOwner | 买入（P） | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital XIV General Partner, LLC TenPercentOwner | 买入（P） | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BCPE Perseus Investor GP, LLC TenPercentOwner | 买入（P） | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BAIN CAPITAL INVESTORS LLC TenPercentOwner | 买入（P） | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-13 2026-04-21 | MTEN Mingteng International Corp Inc. | Xu Yingkai Director,Officer · Chief Executive Officer | 买入（P） | 1,520,000 | US$0.25 | US$380,000.00 | 1,520,000 | SEC |
| 2026-04-07 2026-05-05 | BOT RoboStrategy, Inc. | Kang Andrew Kai Director,Officer,TenPercentOwner · President | 买入（P） | 246,500 | US$10.00 | US$246.5万 | 331,500 | SEC |
| 2026-03-31 2026-04-01 | CRIS CURIS INC | KAITIN KENNETH I Director | 买入（P） | 10,000 | US$0.55 | US$5,500.00 | 11,407 | SEC |
| 2025-06-29 2026-07-08 | EWSB EWSB Bancorp, Inc. /MD/ | Vander Loop Kailee Officer · VP HR Technology | 买入（P） | 7,640 | US$10.00 | US$76,400.00 | 18,163 | SEC |
| 2025-06-29 2026-07-08 | EWSB EWSB Bancorp, Inc. /MD/ | Vander Loop Kailee Officer · VP HR Technology | 买入（P） | 6,040 | US$10.00 | US$60,400.00 | 7,064 | SEC |
| 2025-06-29 2026-07-08 | EWSB EWSB Bancorp, Inc. /MD/ | Vander Loop Kailee Officer · VP HR Technology | 买入（P） | 1,500 | US$10.00 | US$15,000.00 | 5,250 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| KAI | 21,654.0932 | 0 | 28,651.7806 | 75.58% | Q, N |